Skip to main content

View full-text article in PMC

. 2020 Dec 15;21(2):115. doi: 10.3892/ol.2020.12376

Table IV.

Melanoma tumor volume in nude mice before and 48 h after injection of anti-tumor drugs

		Tumor volume,

Item	Primary tumor volume, mm³	First	Second	Third	Fourth	Fifth
T-La (FS)	21.1022±	25.3020±	19.8162±	20.6351±	27.0552±	134.1800±
	2.48719^a	3.04705^b	2.69010^a,b	3.42328^a	5.39173^a	14.22572^a
RGD-T-L (FS)	38.9477±	38.5640±	25.6673±	12.9156±	32.1026±	82.8592±
	11.16416^a	6.22073^b	1.93695^a	15.98864^a	11.98846^a	25.75526^a
T-La	26.6849±	33.3320±	19.5228±	20.0724±	32.6486±	100.7889±
	5.36854^a	8.72730^b	3.78134^a,b	3.76676^a	5.07784^a	10.08681^a
RGD-T-La	24.3425±	27.9720±	10.7225±	18.8990±	32.6512±	83.0283±
	3.35537^a	5.69018^b	2.03661^b	2.16945^a	5.11254^a	18.52589^a
Cisplatin positive control	23.9659±	34.4100±	14.2439±	13.1352±	3.5965±	/
	5.18682^a	7.04033^b	4.04242^a,b	5.14370^a	4.20833^b
PBS blank control	32.2281±	62.0960±	25.9056±	25.8578±	22.9230±	114.2617±
	2.09646^a	5.50607^a	7.16902^a	4.13521^a	3.37649^a	13.95786^a

Data are presented as mean ± SE, n=6.

^a

P<0.05

^b

P<0.001 and ^a,bP>0.05 vs. PBS blank control.